United States Healthcare Equipment & Supplies

Orthofix Medical Inc (OFIX)

Track

Track

Orthofix Medical Inc. experienced recent insider trading activity characterized by executive divestments. Patrick Fisher executed sales totaling approximately $13,067 following the company's August earnings report. These transactions reflect a net negative trend among leadership, occurring while the stock price remains near its fifty-two-week low despite a positive performance surprise in the latest quarterly results.
Ticker: OFIX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Orthofix Medical Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.8
Fisher Patrick President, Global Limb Recon Officer
Transaction date
Planned sale
Price
311.54
Quantity 51,127 +0.1%
Value US$3,020,278
2.8
PATRICK FISHER Officer Officer
Transaction date
Proposed sale
Price
387.50
Quantity 42,634
Value US$2,055,600
2.8
Fisher Patrick President, Global Limb Recon Officer
Transaction date
Sale
Price
367.50
Quantity 43,432 -21.0%
Value US$582,786
2.1
McPherron Aviva Pres, Global Ops & Qual Officer
Transaction date
Sale
Price
9.38
Quantity 3,670 -5.2%
Value US$34,425
2.1
McPherron Aviva Pres, Global Ops & Qual Officer
Transaction date
Sale
Price
9.38
Quantity 3,670 -5.2%
Value US$34,425
3.5
HENNEMAN JOHN B III Non-Executive Director
Transaction date
Purchase
Price
12.26
Quantity 5,000 +5.8%
Value US$61,295
3.5
Cedron Jorge Andres CLO Officer
Transaction date
Sale
Price
12.82
Quantity 3,743 -6.0%
Value US$47,985
3.7
Vitale Lucas CP&BOO Officer
Transaction date
Sale
Price
11.92
Quantity 4,269 -2.6%
Value US$50,886
2.2
CAPPS VICKIE L Non-Executive Director
Transaction date
Purchase
Price
12.45
Quantity 2,400 +9.5%
Value US$29,880
2.2
CAPPS VICKIE L Non-Executive Director
Transaction date
Purchase
Price
12.44
Quantity 100 +0.4%
Value US$1,244
2.2
CAPPS VICKIE L Non-Executive Director
Transaction date
Purchase
Price
12.48
Quantity 2,500 +11.1%
Value US$31,200
3.6
Andrews Julie CFO Officer
Transaction date
Sale
Price
12.55
Quantity 2,363 -2.6%
Value US$29,658
3.7
Vitale Lucas CP&BOO Officer
Transaction date
Sale
Price
12.55
Quantity 1,141 -0.7%
Value US$14,320
2.8
Calafiore Massimo President & CEO Executive Director
Transaction date
Sale
Price
12.55
Quantity 6,031 -1.8%
Value US$75,694
2.8
Fisher Patrick President, Global Limb Recon Officer
Transaction date
Sale
Price
12.55
Quantity 758 -1.5%
Value US$9,514
2.1
McPherron Aviva Pres, Global Ops & Qual Officer
Transaction date
Sale
Price
12.55
Quantity 1,263 -1.8%
Value US$15,852
3.8
REINHARDT MAX President, Global Spine Officer
Transaction date
Sale
Price
12.55
Quantity 1,053 -4.0%
Value US$13,216
3.5
Cedron Jorge Andres CLO Officer
Transaction date
Sale
Price
12.55
Quantity 1,370 -2.1%
Value US$17,195
3.6
Andrews Julie CFO Officer
Transaction date
Sale
Price
12.92
Quantity 2,425 -2.6%
Value US$31,322
3.7
Vitale Lucas CP&BOO Officer
Transaction date
Sale
Price
12.92
Quantity 1,171 -0.7%
Value US$15,125
2.8
Calafiore Massimo President & CEO Executive Director
Transaction date
Sale
Price
12.92
Quantity 6,189 -1.9%
Value US$79,939
2.8
Fisher Patrick President, Global Limb Recon Officer
Transaction date
Sale
Price
12.92
Quantity 778 -1.5%
Value US$10,049
2.1
McPherron Aviva Pres, Global Ops & Qual Officer
Transaction date
Sale
Price
12.92
Quantity 1,296 -1.8%
Value US$16,740
3.8
REINHARDT MAX President, Global Spine Officer
Transaction date
Sale
Price
12.92
Quantity 1,080 -3.9%
Value US$13,950
3.5
Cedron Jorge Andres CLO Officer
Transaction date
Sale
Price
12.92
Quantity 1,405 -2.1%
Value US$18,147
3.6
Andrews Julie CFO Officer
Transaction date
Sale
Price
14.38
Quantity 4,873 -7.7%
Value US$70,074
2.8
Calafiore Massimo President & CEO Executive Director
Transaction date
Sale
Price
15.21
Quantity 9,797 -4.3%
Value US$149,050
2.8
Calafiore Massimo President & CEO Executive Director
Transaction date
Sale
Price
15.82
Quantity 9,600 -4.1%
Value US$151,906
2.8
Fisher Patrick President, Global Orthopedics Officer
Transaction date
Sale
Price
14.21
Quantity 1,996 -6.2%
Value US$28,363
2.1
McPherron Aviva Pres, Global Ops & Qual Officer
Transaction date
Sale
Price
10.51
Quantity 3,728 -7.4%
Value US$39,181
3.8
REINHARDT MAX President, Global Spine Officer
Transaction date
Sale
Price
11.64
Quantity 1,643 -5.6%
Value US$19,125
2.7
Bazaar Alan Lee Non-Executive Director
Transaction date
Purchase
Price
10.92
Quantity 2,250 +7.8%
Value US$24,570
2.7
Bazaar Alan Lee Non-Executive Director
Transaction date
Purchase
Price
12.59
Quantity 2,000 +7.5%
Value US$25,172
2.8
Calafiore Massimo President & CEO Executive Director
Transaction date
Purchase
Price
12.54
Quantity 10,000 +4.5%
Value US$125,400
2.7
Bazaar Alan Lee Non-Executive Director
Transaction date
Purchase
Price
12.62
Quantity 1,990 +8.0%
Value US$25,120
3.5
Cedron Jorge Andres CLO Officer
Transaction date
Sale
Price
13.31
Quantity 3,816 -8.2%
Value US$50,791
3.7
Gillespie Geoffrey C CAO Officer
Transaction date
Sale
Price
15.74
Quantity 76 -0.2%
Value US$1,196
3.7
Gillespie Geoffrey C CAO Officer
Transaction date
Sale
Price
16.60
Quantity 296 -0.7%
Value US$4,914
3.7
Vitale Lucas CP&BOO Officer
Transaction date
Sale
Price
16.60
Quantity 4,287 -3.1%
Value US$71,164
2.8
Calafiore Massimo President & CEO Executive Director
Transaction date
Purchase
Price
17.43
Quantity 9,914 +4.7%
Value US$172,801
3.7
Gillespie Geoffrey C CAO Officer
Transaction date
Sale
Price
18.08
Quantity 187 -0.5%
Value US$3,381
3.7
Gillespie Geoffrey C CAO Officer
Transaction date
Sale
Price
17.79
Quantity 767 -1.9%
Value US$13,645
3.6
Andrews Julie CFO Officer
Transaction date
Sale
Price
17.89
Quantity 4,655 -14.1%
Value US$83,278
3.7
Gillespie Geoffrey C CAO Officer
Transaction date
Sale
Price
17.14
Quantity 227 -0.6%
Value US$3,891
2.8
Calafiore Massimo President & CEO Executive Director
Transaction date
Sale
Price
17.14
Quantity 9,203 -6.9%
Value US$157,757
3.7
Gillespie Geoffrey C CAO Officer
Transaction date
Sale
Price
16.83
Quantity 248 -0.6%
Value US$4,174
2.8
Calafiore Massimo President & CEO Executive Director
Transaction date
Sale
Price
16.83
Quantity 10,078 -7.0%
Value US$169,619
3.7
Gillespie Geoffrey C CAO Officer
Transaction date
Sale
Price
16.97
Quantity 238 -0.6%
Value US$4,039
3.7
Gillespie Geoffrey C CAO Officer
Transaction date
Sale
Price
17.14
Quantity 238 -0.6%
Value US$4,078
3.7
Gillespie Geoffrey C CAO Officer
Transaction date
Sale
Price
17.84
Quantity 26 -0.1%
Value US$464
3.8
Valentine Keith Director Non-Executive Director
Transaction date
Proposed sale
Price
13.89
Quantity 66,665
Value US$925,975
Bostjancic John J. Officer Officer
Transaction date
Proposed sale
Price
11.00
Quantity 33,456
Value US$368,027
Bostjancic John J. Officer Officer
Transaction date
Proposed sale
Price
10.80
Quantity 9,084
Value US$98,110
Keran Patrick L Officer Officer
Transaction date
Proposed sale
Price
11.00
Quantity 28,985
Value US$318,835
3.0
Hinrichs James F. Non-Executive Director
Transaction date
Purchase
Price
13.47
Quantity 7,500 +9.5%
Value US$101,025
3.0
Kenny Kevin J. President of Global Spine Officer
Transaction date
Sale
Price
19.00
Quantity 3,876 -2.6%
Value US$73,644
3.0
Kenny Kevin J. President of Global Spine Officer
Transaction date
Sale
Price
19.00
Quantity 4,367 -2.9%
Value US$82,973
3.0
Kenny Kevin J. Officer Officer
Transaction date
Proposed sale
Price
19.00
Quantity 10,119
Value US$192,261
1.5
Maniar Shweta Non-Executive Director
Transaction date
Sale
Price
17.75
Quantity 4,262 -17.5%
Value US$75,650
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-03 2026-09-01 PlS Planned sale
2.8
Fisher Patrick

President, Global Limb Recon

Officer
51,127 +0.1%
311.54
US$3,020,278 		51,127 +0.1% 311.54 US$3,020,278
2026-09-01 2026-09-01 PrS Proposed sale
2.8
PATRICK FISHER

Officer

Officer
42,634
387.50
US$2,055,600 		42,634 387.50 US$2,055,600
2026-08-20 2026-08-18 S Sale
2.8
Fisher Patrick

President, Global Limb Recon

Officer
43,432 -21.0%
367.50
US$582,786 		43,432 -21.0% 367.50 US$582,786
2026-06-22 2026-06-18 S Sale
2.1
McPherron Aviva

Pres, Global Ops & Qual

Officer
3,670 -5.2%
9.38
US$34,425 		3,670 -5.2% 9.38 US$34,425
2026-06-22 2026-06-18 S Sale
2.1
McPherron Aviva

Pres, Global Ops & Qual

Officer
3,670 -5.2%
9.38
US$34,425 		3,670 -5.2% 9.38 US$34,425
2026-05-08 2026-05-07 B Purchase
3.5
HENNEMAN JOHN B III
Non-Executive Director
5,000 +5.8%
12.26
US$61,295 		5,000 +5.8% 12.26 US$61,295
2026-05-07 2026-05-07 B Purchase
2.2
Engine Capital Management, LP
Large shareholder
904 +0.2%
12.15
US$10,981 		904 +0.2% 12.15 US$10,981
2026-05-07 2026-05-07 B Purchase
2.2
Engine Capital Management, LP
Large shareholder
1,808 +0.5%
12.20
US$22,053 		1,808 +0.5% 12.20 US$22,053
2026-05-07 2026-05-07 B Purchase
2.2
Engine Capital Management, LP
Large shareholder
9,096 +0.2%
12.15
US$110,490 		9,096 +0.2% 12.15 US$110,490
2026-05-07 2026-05-07 B Purchase
2.2
Engine Capital Management, LP
Large shareholder
18,192 +0.5%
12.20
US$221,901 		18,192 +0.5% 12.20 US$221,901
2026-05-07 2026-05-06 B Purchase
2.2
Engine Capital Management, LP
Large shareholder
3,792 +1.0%
12.23
US$46,369 		3,792 +1.0% 12.23 US$46,369
2026-05-07 2026-05-06 B Purchase
2.2
Engine Capital Management, LP
Large shareholder
38,154 +1.0%
12.23
US$466,547 		38,154 +1.0% 12.23 US$466,547
2026-05-07 2026-05-05 B Purchase
2.2
Engine Capital Management, LP
Large shareholder
2,911 +0.8%
11.99
US$34,911 		2,911 +0.8% 11.99 US$34,911
2026-05-07 2026-05-05 B Purchase
2.2
Engine Capital Management, LP
Large shareholder
110,039 +3.0%
11.99
US$1,319,676 		110,039 +3.0% 11.99 US$1,319,676
2026-04-20 2026-04-16 S Sale
3.5
Cedron Jorge Andres

CLO

Officer
3,743 -6.0%
12.82
US$47,985 		3,743 -6.0% 12.82 US$47,985
2026-03-19 2026-03-17 S Sale
3.7
Vitale Lucas

CP&BOO

Officer
4,269 -2.6%
11.92
US$50,886 		4,269 -2.6% 11.92 US$50,886
2026-03-10 2026-03-10 B Purchase
2.2
CAPPS VICKIE L
Non-Executive Director
2,400 +9.5%
12.45
US$29,880 		2,400 +9.5% 12.45 US$29,880
2026-03-10 2026-03-10 B Purchase
2.2
CAPPS VICKIE L
Non-Executive Director
100 +0.4%
12.44
US$1,244 		100 +0.4% 12.44 US$1,244
2026-03-10 2026-03-09 B Purchase
2.2
CAPPS VICKIE L
Non-Executive Director
2,500 +11.1%
12.48
US$31,200 		2,500 +11.1% 12.48 US$31,200
2026-03-06 2026-03-05 S Sale
3.6
Andrews Julie

CFO

Officer
2,363 -2.6%
12.55
US$29,658 		2,363 -2.6% 12.55 US$29,658
2026-03-06 2026-03-05 S Sale
3.7
Vitale Lucas

CP&BOO

Officer
1,141 -0.7%
12.55
US$14,320 		1,141 -0.7% 12.55 US$14,320
2026-03-06 2026-03-05 S Sale
2.8
Calafiore Massimo

President & CEO

Executive Director
6,031 -1.8%
12.55
US$75,694 		6,031 -1.8% 12.55 US$75,694
2026-03-06 2026-03-05 S Sale
2.8
Fisher Patrick

President, Global Limb Recon

Officer
758 -1.5%
12.55
US$9,514 		758 -1.5% 12.55 US$9,514
2026-03-06 2026-03-05 S Sale
2.1
McPherron Aviva

Pres, Global Ops & Qual

Officer
1,263 -1.8%
12.55
US$15,852 		1,263 -1.8% 12.55 US$15,852
2026-03-06 2026-03-05 S Sale
3.8
REINHARDT MAX

President, Global Spine

Officer
1,053 -4.0%
12.55
US$13,216 		1,053 -4.0% 12.55 US$13,216
2026-03-06 2026-03-05 S Sale
3.5
Cedron Jorge Andres

CLO

Officer
1,370 -2.1%
12.55
US$17,195 		1,370 -2.1% 12.55 US$17,195
2026-03-06 2026-03-04 S Sale
3.6
Andrews Julie

CFO

Officer
2,425 -2.6%
12.92
US$31,322 		2,425 -2.6% 12.92 US$31,322
2026-03-06 2026-03-04 S Sale
3.7
Vitale Lucas

CP&BOO

Officer
1,171 -0.7%
12.92
US$15,125 		1,171 -0.7% 12.92 US$15,125
2026-03-06 2026-03-04 S Sale
2.8
Calafiore Massimo

President & CEO

Executive Director
6,189 -1.9%
12.92
US$79,939 		6,189 -1.9% 12.92 US$79,939
2026-03-06 2026-03-04 S Sale
2.8
Fisher Patrick

President, Global Limb Recon

Officer
778 -1.5%
12.92
US$10,049 		778 -1.5% 12.92 US$10,049
2026-03-06 2026-03-04 S Sale
2.1
McPherron Aviva

Pres, Global Ops & Qual

Officer
1,296 -1.8%
12.92
US$16,740 		1,296 -1.8% 12.92 US$16,740
2026-03-06 2026-03-04 S Sale
3.8
REINHARDT MAX

President, Global Spine

Officer
1,080 -3.9%
12.92
US$13,950 		1,080 -3.9% 12.92 US$13,950
2026-03-06 2026-03-04 S Sale
3.5
Cedron Jorge Andres

CLO

Officer
1,405 -2.1%
12.92
US$18,147 		1,405 -2.1% 12.92 US$18,147
2026-02-26 2026-02-25 B Purchase
2.2
Engine Capital Management, LP
Large shareholder
3,102 +0.8%
12.96
US$40,212 		3,102 +0.8% 12.96 US$40,212
2026-02-26 2026-02-25 B Purchase
2.2
Engine Capital Management, LP
Large shareholder
9,959 +0.3%
12.96
US$129,103 		9,959 +0.3% 12.96 US$129,103
2026-02-26 2026-02-24 B Purchase
2.2
Engine Capital Management, LP
Large shareholder
7,721 +2.1%
12.55
US$96,864 		7,721 +2.1% 12.55 US$96,864
2026-02-26 2026-02-24 B Purchase
2.2
Engine Capital Management, LP
Large shareholder
117,076 +3.3%
12.55
US$1,468,777 		117,076 +3.3% 12.55 US$1,468,777
2026-01-21 2026-01-16 S Sale
3.6
Andrews Julie

CFO

Officer
4,873 -7.7%
14.38
US$70,074 		4,873 -7.7% 14.38 US$70,074
2026-01-13 2026-01-12 S Sale
2.8
Calafiore Massimo

President & CEO

Executive Director
9,797 -4.3%
15.21
US$149,050 		9,797 -4.3% 15.21 US$149,050
2026-01-13 2026-01-09 S Sale
2.8
Calafiore Massimo

President & CEO

Executive Director
9,600 -4.1%
15.82
US$151,906 		9,600 -4.1% 15.82 US$151,906
2025-08-20 2025-08-18 S Sale
2.8
Fisher Patrick

President, Global Orthopedics

Officer
1,996 -6.2%
14.21
US$28,363 		1,996 -6.2% 14.21 US$28,363
2025-07-07 2025-07-02 B Purchase
2.2
Engine Capital Management, LP
Large shareholder
1,250 +0.0%
11.11
US$13,881 		1,250 +0.0% 11.11 US$13,881
2025-06-23 2025-06-18 S Sale
2.1
McPherron Aviva

Pres, Global Ops & Qual

Officer
3,728 -7.4%
10.51
US$39,181 		3,728 -7.4% 10.51 US$39,181
2025-06-13 2025-06-11 S Sale
3.8
REINHARDT MAX

President, Global Spine

Officer
1,643 -5.6%
11.64
US$19,125 		1,643 -5.6% 11.64 US$19,125
2025-06-05 2025-06-04 B Purchase
2.7
Bazaar Alan Lee
Non-Executive Director
2,250 +7.8%
10.92
US$24,570 		2,250 +7.8% 10.92 US$24,570
2025-05-12 2025-05-12 B Purchase
2.7
Bazaar Alan Lee
Non-Executive Director
2,000 +7.5%
12.59
US$25,172 		2,000 +7.5% 12.59 US$25,172
2025-05-12 2025-05-09 B Purchase
2.8
Calafiore Massimo

President & CEO

Executive Director
10,000 +4.5%
12.54
US$125,400 		10,000 +4.5% 12.54 US$125,400
2025-05-12 2025-05-09 B Purchase
2.7
Bazaar Alan Lee
Non-Executive Director
1,990 +8.0%
12.62
US$25,120 		1,990 +8.0% 12.62 US$25,120
2025-05-08 2025-05-07 B Purchase
2.2
Engine Capital Management, LP
Large shareholder
8,519 +2.4%
12.31
US$104,869 		8,519 +2.4% 12.31 US$104,869
2025-05-08 2025-05-07 B Purchase
2.2
Engine Capital Management, LP
Large shareholder
8,106 +2.4%
12.31
US$99,785 		8,106 +2.4% 12.31 US$99,785
2025-05-08 2025-05-07 B Purchase
2.2
Engine Capital Management, LP
Large shareholder
83,375 +2.4%
12.31
US$1,026,346 		83,375 +2.4% 12.31 US$1,026,346
2025-04-18 2025-04-16 S Sale
3.5
Cedron Jorge Andres

CLO

Officer
3,816 -8.2%
13.31
US$50,791 		3,816 -8.2% 13.31 US$50,791
2025-04-04 2025-04-02 S Sale
3.7
Gillespie Geoffrey C

CAO

Officer
76 -0.2%
15.74
US$1,196 		76 -0.2% 15.74 US$1,196
2025-03-20 2025-03-18 S Sale
3.7
Gillespie Geoffrey C

CAO

Officer
296 -0.7%
16.60
US$4,914 		296 -0.7% 16.60 US$4,914
2025-03-20 2025-03-18 S Sale
3.7
Vitale Lucas

CP&BOO

Officer
4,287 -3.1%
16.60
US$71,164 		4,287 -3.1% 16.60 US$71,164
2025-03-06 2025-03-05 B Purchase
2.8
Calafiore Massimo

President & CEO

Executive Director
9,914 +4.7%
17.43
US$172,801 		9,914 +4.7% 17.43 US$172,801
2025-02-05 2025-02-04 S Sale
3.7
Gillespie Geoffrey C

CAO

Officer
187 -0.5%
18.08
US$3,381 		187 -0.5% 18.08 US$3,381
2025-02-05 2025-02-03 S Sale
3.7
Gillespie Geoffrey C

CAO

Officer
767 -1.9%
17.79
US$13,645 		767 -1.9% 17.79 US$13,645
2025-01-21 2025-01-16 S Sale
3.6
Andrews Julie

CFO

Officer
4,655 -14.1%
17.89
US$83,278 		4,655 -14.1% 17.89 US$83,278
2025-01-14 2025-01-13 S Sale
3.7
Gillespie Geoffrey C

CAO

Officer
227 -0.6%
17.14
US$3,891 		227 -0.6% 17.14 US$3,891
2025-01-14 2025-01-13 S Sale
2.8
Calafiore Massimo

President & CEO

Executive Director
9,203 -6.9%
17.14
US$157,757 		9,203 -6.9% 17.14 US$157,757
2025-01-14 2025-01-10 S Sale
3.7
Gillespie Geoffrey C

CAO

Officer
248 -0.6%
16.83
US$4,174 		248 -0.6% 16.83 US$4,174
2025-01-14 2025-01-10 S Sale
2.8
Calafiore Massimo

President & CEO

Executive Director
10,078 -7.0%
16.83
US$169,619 		10,078 -7.0% 16.83 US$169,619
2025-01-10 2025-01-08 S Sale
3.7
Gillespie Geoffrey C

CAO

Officer
238 -0.6%
16.97
US$4,039 		238 -0.6% 16.97 US$4,039
2025-01-10 2025-01-07 S Sale
3.7
Gillespie Geoffrey C

CAO

Officer
238 -0.6%
17.14
US$4,078 		238 -0.6% 17.14 US$4,078
2024-12-19 2024-12-17 S Sale
3.7
Gillespie Geoffrey C

CAO

Officer
26 -0.1%
17.84
US$464 		26 -0.1% 17.84 US$464
2023-12-21 2023-12-18 PrS Proposed sale
3.8
Valentine Keith

Director

Non-Executive Director
66,665
13.89
US$925,975 		66,665 13.89 US$925,975
2023-11-20 2023-11-20 PrS Proposed sale
Bostjancic John J.

Officer

Officer
33,456
11.00
US$368,027 		33,456 11.00 US$368,027
2023-11-09 2023-11-09 PrS Proposed sale
Bostjancic John J.

Officer

Officer
9,084
10.80
US$98,110 		9,084 10.80 US$98,110
2023-11-09 2023-11-09 PrS Proposed sale
Keran Patrick L

Officer

Officer
28,985
11.00
US$318,835 		28,985 11.00 US$318,835
2023-09-14 2023-09-14 B Purchase
3.0
Hinrichs James F.
Non-Executive Director
7,500 +9.5%
13.47
US$101,025 		7,500 +9.5% 13.47 US$101,025
2023-05-26 2023-05-26 S Sale
3.0
Kenny Kevin J.

President of Global Spine

Officer
3,876 -2.6%
19.00
US$73,644 		3,876 -2.6% 19.00 US$73,644
2023-05-26 2023-05-24 S Sale
3.0
Kenny Kevin J.

President of Global Spine

Officer
4,367 -2.9%
19.00
US$82,973 		4,367 -2.9% 19.00 US$82,973
2023-05-24 2023-05-24 PrS Proposed sale
3.0
Kenny Kevin J.

Officer

Officer
10,119
19.00
US$192,261 		10,119 19.00 US$192,261
2023-04-05 2023-03-10 S Sale
1.5
Maniar Shweta
Non-Executive Director
4,262 -17.5%
17.75
US$75,650 		4,262 -17.5% 17.75 US$75,650
Explore more

More insider trading research around Orthofix Medical Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America